AA USA Trading Inc. of South River, NJ is recalling ginger slice products packaged under the AA brand in 8-ounce plastic bags, because they may contain undeclared sulfites. People who have an allergy or severe sensitivity to sulfites the risk of serious or life-threatening allergic reaction if they consume these products.
FDA approves Cinqair to treat severe asthma
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.
FDA approves new psoriasis drug Taltz
The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis.
FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death
In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death. Today’s actions are among a number of steps the agency recently outlined in a plan to reassess its approach to opioid medications. The plan is focused on policies aimed at reversing the epidemic, while still providing patients in pain access to effective relief.
NOW Health Group, Inc. Voluntarily Recalls Limited Quantity of Six Dietary Supplements Due to Mislabeling
Bloomingdale, Ill. – NOW Health Group, Inc. is voluntarily recalling limited quantities of six dietary supplements that are mislabeled due to a printing error from the label supplier. The recall affects approximately 165 total units that were distributed nationally and sold in retail stores and online.
H-E-B Issues Voluntary Recall: Select 5oz Hill Country Fare Chunk Light Tuna in Oil Recalled for Potential Health Risk
H-E-B is voluntarily recalling 224 cases (10,752 cans) of Hill Country Fare brand 5 oz. Chunk Light Tuna in Oil. This recall has been initiated because the product, produced at a co-packer, may have been undercooked due to an equipment malfunction, which was uncovered during a routine inspection.
FDA proposes ban on most powdered medical gloves
Today, the U.S. Food and Drug Administration announced a proposal to ban most powdered gloves in the United States. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness or injury to health care providers, patients and other individuals who are exposed to them, which cannot be corrected through new or updated labeling.
Hospira Issues a Voluntary Recall for One Lot of Sodium Bicarbonate Injection, USP Due to the Presence of a Particulate
Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of 8.4% Sodium Bicarbonate Injection, USP (NDC: 0409-6625-02, Lot 56-148-EV, Expiry 1AUG2017) at the hospital/retail level due to the presence of a particulate within a single-dose glass fliptop vial. The issue was identified through a confirmed complaint.
FDA approves new treatment for inhalation anthrax
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
MFA Incorporated issues recall on rabbit feed pellets (both bagged and bulk) in southwest Missouri due to excessive sodium
MFA Incorporated today announced the recall of bagged and bulk MFA 16% and 17% rabbit feed. The product was distributed to MFA retail stores in southwest Missouri.
Read The Complete Story!